Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:
EVA, OTCQB: AXHLF) (the “Company”) announces that it has reimaged its look and presence to correspond to its expanding evolution
in the medical technology, health and life sciences worlds.
“As a Company that has primarily focussed on autonomous medical care, we continually bump up against the
intersection of the device world and the biology of wellness. We realize that in order to grow and be successful with these
two disciplines that co-exist and add value to each other; both need to be part of our Company’s development” Said Ron
Ozols, Director of the Company. “We see tremendous value in partnering or acquiring projects that offer this
opportunity. We are interested in projects that make protocols better and more effective within the human condition.
There have been significant strides made in molecular biology and the genetics of plants that increase bioavailability and
efficacy for nutraceutical and pharmaceutical protocols that are of high interest to us. From Astaxanthin to Spirulina and
Zeolites there is much research and new developments are beginning to emerge.”
Management continues to strive to seek optimal business and commercialization strategies for the Company, including
the recent acquisition of the Artillery Labs platform, and various other opportunities currently being pursued. This, with
the recent re-engagement of Haywood Securities for financial advisory services, and with Mr. C.K. Cheung as the new CEO, the
Company is moving forward for a exciting and robust future.
Contact: Ron Ozols, or C.K. Cheung, Directors
EVITRADE Health Systems Corporation
(formerly Auxellence Health Corporation)
Email info@evahealthsystems.com
Website http://www.evahealthsystems.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp
US OTC Markets: http://www.otcmarkets.com/stock/AXHLF/news
About EVITRADE Health (CSE: EVA, OTCQB: AXHLF)
EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online “digital healthcare”
services for resolving common health problems. The current markets are weight-loss, high blood pressure, high blood glucose and
heart arrhythmia.
Disclaimers – Forward Looking Statements
This news release contains forward-looking statements based on assumptions and judgments of management regarding
future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or
results to differ materially from those reflected in the forward looking statements. The Company disclaims any intention or
obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its
business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings
with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp,
and http://www.otcmarkets.com/stock/AXHLF/filings. This news release
does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly
undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation
Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this
release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities
described herein in the United States. The securities described herein have not been registered under the United States
Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the
“United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the
U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
To view the original release, please click here
Source: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)
To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the
icons below.
Maximum News Dissemination by FSCwire. https://www.fscwire.com
Copyright © 2018 FSCwire